Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations

Muhammad A. Mir, Samith T. Kochuparambil, Roshini S. Abraham, Vilmarie Rodriguez, Matthew Howard, Amy P. Hsu, Amie E. Jackson, Steven M. Holland, Mrinal M. Patnaik

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Guanine-adenine-thymine-adenine 2 (GATA2) mutated disorders include the recently described MonoMAC syndrome (Monocytopenia and Mycobacterium avium complex infections), DCML (dendritic cell, monocyte, and lymphocyte deficiency), familial MDS/AML (myelodysplastic syndrome/acute myeloid leukemia) (myeloid neoplasms), congenital neutropenia, congenital lymphedema (Emberger's syndrome), sensorineural deafness, viral warts, and a spectrum of aggressive infections seen across all age groups. While considerable efforts have been made to identify the mutations that characterize this disorder, pathogenesis remains a work in progress with less than 100 patients described in current literature. Varying clinical presentations offer diagnostic challenges. Allogeneic stem cell transplant remains the treatment of choice. Morbidity, mortality, and social costs due to the familial nature of the disease are considerable. We describe our experience with the disorder in three affected families and a comprehensive review of current literature.

Original languageEnglish (US)
Pages (from-to)490-499
Number of pages10
JournalCancer medicine
Issue number4
StatePublished - Apr 1 2015


  • GATA2
  • Leukemia
  • Lymphedema
  • MonoMAC
  • Viral warts

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research


Dive into the research topics of 'Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations'. Together they form a unique fingerprint.

Cite this